Doxorubicin resistance in breast cancer is mediated via the activation of FABP5/PPARγ and CaMKII signaling pathway

por Chen, Nan-Nan, Ma, Xin-Di, Miao, Zhuang, Zhang, Xiang-Mei, Han, Bo-Ye, Almaamari, Ahmed Ali, Huang, Jia-Min, Chen, Xue-Yan, Liu, Yun-Jiang, Su, Su-Wen
Publicado 2023